ADVERTISEMENT
SAMHSA grants will encourage wider access to naloxone
Methadone treatment programs and waivered buprenorphine prescribers are among those eligible for newly announced federal grants for development of best practices for the prescribing of the overdose reversal drug naloxone to high-need populations.
Up to five grantees will receive a maximum of $200,000 a year for five years under the Substance Abuse and Mental Health Services Administration's (SAMHSA's) Improving Access to Overdose Treatment grant program. Grant recipients will partner with other prescribers at the community level to develop best practices for prescribing overdose reversal drugs, and will engage in training that is targeted to prescribers and members of the public.
Eligibility is limited to federally qualified health centers (FQHCs), opioid treatment programs (OTPs), and practitioners waivered to prescribe buprenorphine.
The application deadline is June 4. Click here for the grant program announcement.
